As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

New Members Bring Expertise in Immunology, Genomics, Clinical Oncology, and Patient Advocacy to Guide LCFA's Research Investments and Accelerate Breakthroughs ...

KRAS is the most frequently mutated oncogene across all human cancers. Although different KRAS mutations have long been thought to exert the same cancer-driving effects, a new study led by UT ...

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response ...

Scientists at Mayo Clinic have discovered that a drug originally developed for lung cancer could help make a common ovarian cancer treatment more effective. The research reveals why some ovarian ...

(Boston)—Throughout a person’s lifetime, the cells lining the respiratory tract are exposed to inhaled pollutants, including cigarette smoke. These exposures can cause molecular changes that disrupt ...

Lung cancer remains the leading cause of cancer-related mortality globally. The detection rate of nodules has significantly increased with the implementation of health screening using low-dose spiral ...

Research programs fuel innovation in early detection, treatment, and health equity for lung cancer. WASHINGTON, Jan. 15, 2026 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung ...

The UCSF Helen Diller Family Comprehensive Cancer Center announced today the awarding of a Specialized Programs of Research Excellence (SPORE) grant by the National Cancer Institute (NCI) for a ...

The lungs and the central nervous system are closely linked through blood circulation and neural pathways. Lung diseases can affect brain structure and ...